Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-47
SponsorGeneration Next Fertility
About this trial
Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
No none contraindications to IVF or PRP treatment
Adequate ovarian reserves and AMH level
Willingness to undergo two IVF cycles and oPRP treatment
Disqualifiers
Anovulation due to menopause or perimenopause
Any health conditions that are contraindicated for IVF or oPRP treatment
Trial design
Design model
Single group
Treatments tested in this trial
Ovarian Platelet-rich plasma (PRP) injections
Procedure/SurgeryThis is a procedure that our patients receive at our clinic. We want to use the AI software to evaluate embryo development before and after treatment to see if there is a difference in embryo quality after PRP treatment within the same patient.
Treatment groups
180 Participants
are divided into 1 treatment groupGroup A: Embryo Development Before and After Ovarian PRP Using Time-Lapse AI Embryo Quality ScoreExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Blastocyst formation and embryo quality
The number of high quality embryos that are created per cycle
Time frame
1 yearSecondary outcomes
1
Live birth rate per transfer
The number of live births following embryo transfer
Time frame
2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov